News
AstraZeneca begins Phase III trial of Covid-19 vaccine in US
AstraZeneca has expanded the clinical development of its potential Covid-19 vaccine candidate AZD1222 in the US, by initiating a Phase 3 clinical trial, dubbed D8110C00001.
The late-stage clinical trial is aimed at evaluating the safety, efficacy and immunogenicity of the...
News
Sanofi provides update on Kevzara Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S.
Sanofi announced that the global Phase 3 trial investigating intravenously administered Kevzara® (sarilumab) at a dose of 200 mg or 400 mga in severely or critically illb patients hospitalized with COVID-19 did not meet its primary endpoint and key...
Drug Research
Piramal Pharma to Collaboratewith Epirium Bio on Exclusive Integrated Development & Manufacturing Program for Orphan Drugs
Piramal Pharma Solutions, a leading contract development and manufacturing organization (CDMO), today announced that the company will be partnering with Epirum Bio on an exclusivemanufacturing relationship fornew orphan drugs targeting rare diseases with high unmetneeds.
The Piramal Pharma Solutions (PPS)...
Clinical Trials
Bayer submits vericiguat for marketing authorization in China for the treatment of chronic heart failure
Bayer announced the submission of the regulatory application seeking the approval of vericiguat in China. Vericiguat is an investigational oral, once-daily, first-in-class soluble guanylate cyclase (sGC)-stimulator being developed to treat patients with symptomatic chronic heart failure with an ejection...
News
Gilead’s Investigational Antiviral Veklury Receives U.S. FDA Emergency Use Authorization for the Treatment of Patients With Moderate COVID-19
Gilead Sciences, Inc. announced the U.S. FDA expanded the EUA enabling use of the investigational antiviral Veklury® (remdesivir) to treat all hospitalized patients with COVID-19, in addition to the previous authorization for patients hospitalized with severe COVID-19. The expanded...
News
Chiesi Group and JAGGAER Drive Strategic Supplier Management and Procurement Excellence
Chiesi Group, an international pharmaceutical corporation focused on research, development, and production of innovative medicines, has selected JAGGAER, the world’s largest independent spend management company, to strategically and progressively advance and expand its supplier management program across its 29...
News
Bruker and Purity-IQ sign partnership agreement to transform the cannabis regulatory landscape
Bruker and Purity-IQ have joined forces to create a powerful new testing system for medical cannabis in Canada. The Purity-IQ Cannabis Fingerprint™ combines Bruker’s expertise in nuclear magnetic resonance (NMR) based screening technology with Purity-IQ’s genomics capabilities to offer...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read